CAM
ORGO icon

ClariVest Asset Management’s Organogenesis Holdings ORGO Stock Holding History

ClariVest Asset Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-64,366
Closed -$314K – 740
2022
Q2 		$314K Sell
64,366
-61
-0.1% -$375 0.01% 426
2022
Q1 		$490K Buy
64,427
+22,226
+53% +$172K 0.02% 387
2021
Q4 		$390K Sell
42,201
-2,560
-6% -$27.2K 0.01% 452
2021
Q3 		$637K Sell
44,761
-1,911
-4% -$29.7K 0.02% 401
2021
Q2 		$776K Buy
+46,672
New +$870K 0.03% 346

Other funds holding ORGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

ClariVest Asset Management's ORGO Position: Q3 2022 in Review

ClariVest Asset Management sold out of Organogenesis Holdings (ORGO) in Q3 2022, closing a stake of 64,366 shares — an estimated $314K sold.

ClariVest Asset Management first reported a position in ORGO in Q2 2021 and held it in 5 quarters. The position peaked at $776K in Q2 2021. 154 funds tracked by Wall St. Rank hold ORGO as of Q3 2022.

  • ClariVest Asset Management reported no remaining Organogenesis Holdings position as of Q3 2022 after selling out during the quarter.
  • ClariVest Asset Management sold 64,366 Organogenesis Holdings shares in Q3 2022, an estimated $314K.
  • ClariVest Asset Management first reported a position in Organogenesis Holdings in Q2 2021 and held it in 5 quarters.
  • ClariVest Asset Management's Organogenesis Holdings position peaked at $776K in Q2 2021.
  • 154 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2022.

Based on ClariVest Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.